Concepedia

Kadri Kangro

KK

14

Publications

922

Citations

12

H-Index

2018

Active since

Affiliations

KU Leuven(Current)

Icosagen (Estonia)

Sorbonne Université

Sanquin

Amsterdam UMC Location University of Amsterdam

Kadri Kangro is an author at KU Leuven specializing in immunology, medicine, and vaccine development.

ORCID

Top concepts

Publications per year

2018–2023

14

Publications

14

Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study

Paul Naaber, Liina Tserel, Kadri Kangro et al. · The Lancet Regional Health - Europe · 2021 · 667 citations · Full text

Anti-ADAMTS13 Autoantibodies against Cryptic Epitopes in Immune-Mediated Thrombotic Thrombocytopenic Purpura

Elien Roose, Gestur Vidarsson, Kadri Kangro et al. · Thrombosis and Haemostasis · 2018 · 33 citations · Full text

Declined antibody responses to COVID-19 mRNA vaccine within first three months

Paul Naaber, Liina Tserel, Kadri Kangro et al. · 2021 · 24 citations · Full text

, , +16

Modifying ADAMTS13 to modulate binding of pathogenic autoantibodies of patients with acquired thrombotic thrombocytopenic purpura

Nuno A. G. Graça, Bogac Ercig, Leydi Carolina Velásquez Pereira et al. · Haematologica · 2019 · 23 citations · Full text

Anti-ADAMTS13 autoantibody profiling in patients with immune-mediated thrombotic thrombocytopenic purpura

Kadri Kangro, Elien Roose, Bérangère S. Joly et al. · Blood Advances · 2021 · 23 citations · Full text

Rows per page

1–5 of 14